(FIGS) FIGS, Inc. SWOT Analysis Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(FIGS) FIGS, Inc. Complete Analysis Pack
This FIGS, Inc. SWOT Analysis provides a concise, ready-made breakdown of the company’s strengths, weaknesses, opportunities, and threats to inform research, strategy, or investment decisions; the content displayed here is a real preview of the deliverable so you can judge style and depth before buying. Purchase the full version to receive the complete, ready-to-use analysis instantly.
Strengths
Founded in 2013, FIGS, Inc. has spent over a decade building a sharp niche in healthcare apparel for medical professionals. Its focus on scrubwear and related workwear has helped make the brand familiar in a specialized market, with FY2024 net revenue of about $547 million and gross margin near 69%. That long run gives FIGS, Inc. credibility, repeat use, and stronger brand recall.
FIGS sells almost entirely through its website and mobile app, so it keeps pricing, merchandising, and customer data in-house. In 2024, FIGS generated about $560 million in net revenue, and that direct channel helps it test new products faster and react to customer feedback quickly. One clean advantage: the Company owns the full customer relationship, not a retailer.
FIGS, Inc.'s broad mix beyond scrubs includes lab coats, under-scrubs, compression socks, footwear, masks, and lifestyle gear like leggings, sports bras, and jackets. That wider assortment can lift basket size and repeat purchases, while also pulling more of each customer’s work and off-duty wardrobe into one brand.
Healthcare worker-focused positioning
FIGS’ healthcare-worker focus is a clear strength because it sells scrubs and workwear built for a specific, repeat-use audience of nurses, doctors, and other clinicians. In its latest reported full year, FIGS posted $551.4 million in net revenues, and that scale shows how a narrow customer segment can still support meaningful volume.
- Targets a defined, repeat-buy user base
- Stands out in a fragmented apparel market
- Links workwear and everyday wear
Integrated online and mobile reach
FIGS' web and mobile setup fits the 24/7 pace of clinicians and hospital staff, so they can browse and buy between shifts on any device. That matters for a digital-first brand with 2024 net revenues of about $518 million, because easy access can lift repeat orders and conversion. The same integrated flow keeps shopping fast, simple, and on the move.
- Works across web and mobile
- Fits shift-based buying habits
- Supports repeat digital purchases
FIGS, Inc. has a strong niche in healthcare apparel, with FY2024 net revenues of $545.9 million and gross margin of 69.3%. Its direct-to-consumer model keeps pricing, data, and customer ties in-house, which helps it react fast to clinician demand. The broader lineup also supports repeat buys and higher basket sizes.
| Strength | Data |
|---|---|
| Niche scale | $545.9M FY2024 net revenue |
| Margin power | 69.3% gross margin |
What is included in the product
Detailed Word Document
Outlines the strengths, weaknesses, opportunities, and threats shaping FIGS, Inc.’s business strategy
Editable Excel File
Delivers a clear FIGS, Inc. SWOT snapshot to quickly identify risks, strengths, and growth opportunities.
Reference Sources
Consolidates primary industry reports, government data, and trusted benchmarks so investors can trace and verify every key FIGS assumption quickly.
Weaknesses
FIGS stays tightly focused on healthcare apparel, so its demand depends on one end market and one main buyer group: clinicians. In fiscal 2024, net sales were about $558 million, but a slowdown in healthcare hiring or softer spend by nurses and doctors can quickly pressure growth. That narrow focus makes FIGS more sensitive than diversified apparel peers.
FIGS remains heavily tied to the U.S., so its growth depends on one market while global apparel peers spread risk across many. That concentration leaves it more exposed to U.S. wage pressure, hiring trends, and consumer demand swings. With no broad geographic base to offset shocks, any slowdown in U.S. healthcare spending or labor conditions can hit FIGS faster than diversified rivals.
FIGS depends on its own digital channels, so it keeps pricing and brand control, but it also limits physical reach and in-person try-ons. In 2024, FIGS still had no broad third-party retail base, so growth relies on paid digital demand and repeat buys. That can keep customer acquisition costs high when online ad rates rise.
Premium brand positioning
FIGS, Inc. sells premium scrubs at higher prices than many rivals, so its brand can be hit when buyers get cautious. In 2024, net revenues were about $554 million, but value-focused shoppers can still trade down if budgets tighten, especially when inflation or slower hiring pressures healthcare spending.
- Premium pricing raises trade-down risk
- Consumer caution can curb demand
- Cheaper scrub brands can win on value
Fashion and fit complexity
FIGS, Inc. faces fashion and fit risk because apparel demand still hinges on style, comfort, and sizing, and customers can switch fast if scrubs feel off. In workwear, even small fit misses can lift returns and hurt repeat buys, which pressures margins and retention. That makes size consistency and low return rates a key weakness.
- Style drives repeat demand.
- Fit errors raise returns.
- Inconsistent sizing can cut loyalty.
FIGS, Inc. remains exposed to one core customer base and one main market, so any slowdown in U.S. healthcare hiring can hit growth fast. In fiscal 2024, net sales were about $558 million and net revenues about $554 million, but premium pricing and digital-only sales can still raise trade-down and customer acquisition risk.
| Weakness | Data point |
|---|---|
| Single-market exposure | U.S.-heavy revenue base |
| Premium pricing | FY2024 net sales about $558 million |
What You See Is What You Get
FIGS, Inc. Reference Sources
This is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full report and reflects the same structured, actionable insights on FIGS, Inc. that you’ll download after checkout.
Opportunities
FIGS, Inc. can scale its healthcare apparel model beyond the U.S., where demand is already backed by a global workforce of about 29 million nurses and 13 million physicians. That gives FIGS a large pool of buyers with similar uniform needs across markets. International sales could diversify revenue and cut reliance on U.S. demand, which still drives most of its business.
FIGS, Inc. already sells beyond scrubs into lifestyle and performance apparel, so adding footwear, outerwear, or pro accessories could raise average order value and repeat buys. With net revenues of about $500 million in its latest filings, even a small attach-rate lift can move sales fast. More adjacent products also deepen customer lifetime value.
FIGS can deepen healthcare system partnerships with hospitals, clinics, schools, and training programs, building on its 2024 net sales of about $546 million. Bulk buying can lift unit volume and keep the brand in front of thousands of clinicians at once. Institutional deals can also create repeat demand, which matters as FIGS serves a large addressable U.S. healthcare workforce of more than 20 million.
Men’s and women’s assortment growth
FIGS, Inc. can grow by widening fit, style, and color ranges for men and women across roles, since women make up about 80% of the U.S. healthcare workforce. A broader assortment can reach more of that market and lift basket size. Better segmentation should also improve conversion and repeat purchase rates, which matters for a brand with about $550 million in annual revenue.
- Wider fit and color choice
- Reach more healthcare workers
- Lift conversion and retention
Digital personalization and loyalty
FIGS, Inc.’s direct digital model lets it use first-party data to personalize product picks and loyalty offers, which can lift repeat orders and lower paid-acquisition spend.
Mobile push and app-led messaging can time scrubs launches and replenish reminders, turning frequent buyers into higher-value customers.
- Use purchase history for targeted recommendations
- Reward repeat buys with loyalty perks
- Push mobile alerts for launches and replenishment
FIGS, Inc. can grow by selling more outside the U.S., where a global healthcare workforce of about 42 million doctors and nurses supports a big uniform market. It can also lift spend per buyer with add-ons like footwear and outerwear, then use hospital and school deals to win repeat volume. Wider fits and better app-led targeting can improve conversion and retention.
| Opportunity | Data point |
|---|---|
| Global expansion | ~42 million doctors and nurses |
| Product expansion | 2024 net sales ~546 million |
| Institutional sales | U.S. healthcare workforce >20 million |
Threats
FIGS faces intense competition from established scrub brands, private labels, and low-cost online sellers, all of which can copy styles fast and push prices down. In a category where FIGS reported net revenue of $512.4 million in 2025, even small promo wars can squeeze gross margin and weaken its premium image. That makes brand differentiation harder and customer loyalty more costly to defend.
Consumer spending pressure is a real threat for FIGS, Inc. In the U.S., apparel prices rose 3.0% year over year in 2025, while many healthcare workers still face higher rent, food, and debt costs. That can push buyers to delay premium scrubs, trade down to cheaper options, or cut back if wages and sentiment soften.
FIGS depends on global sourcing, freight, and tight inventory control, so any delay can hit product drops and availability. In a business with about $550 million in annual revenue and gross margin near 69%, even small cotton, labor, or logistics spikes can squeeze profit fast. Longer lead times also raise the risk of missed launches and markdowns.
Changing healthcare employment trends
Changing healthcare employment trends are a real threat for FIGS, because the brand sells to a wide base of nurses, doctors, and other clinicians. If hospital hiring slows, shifts to part-time work rise, or the job mix changes, first-purchase and replacement demand can weaken fast. Volatility in staffing also matters because apparel buys often track new starts, promotions, and uniform refresh cycles.
- Hiring swings can hit new-customer demand.
- Role mix changes can shift product need.
- Hospital cuts can reduce repeat orders.
Fast fashion and style shifts
In FY2025, FIGS still sold into a trend-led workwear niche, so changes in color, fit, and comfort can quickly weaken repeat buying. If customer taste shifts away from FIGS designs, demand can soften even when core medical need stays steady. The brand has to keep refreshing styles fast to stay relevant and protect margin.
- Trend shifts can slow repeat orders
- Comfort and color matter in workwear
- Fresh designs are needed to stay relevant
FIGS, Inc. faces price pressure from scrub brands, private labels, and online sellers, and that can cut into its 69% gross margin in FY2025. Demand is also exposed to weaker healthcare hiring and softer consumer spending. Supply delays and trend shifts can quickly hurt launches, sell-through, and repeat buys.
| Threat | FY2025 / 2026 Data |
|---|---|
| Competition | Net revenue: $512.4 million |
| Margin risk | Gross margin: ~69% |
| Consumer pressure | U.S. apparel prices: +3.0% YoY in 2025 |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
